Further assessment of frequencies and relative levels of other effector T cell populations in tumor versus STM showed a notable shift in the ratio of IFNγ+ to IL-17A+ T cell frequencies (on both CD4+ and CD8+ T cell subsets). This evidence concerns the gene CD8A and neoplasm.